In line with declining IL-4 concentration along with increasing cancer aggressiveness in ESCC and CRC, IL4 expression was lower in ESCC cancers metastasizing to lymph nodes and tended to be inversely correlated with primary tumor extension in CRC. The gene discussed is IL4; the disease is neoplasm.